Shay Capital LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Shay Capital LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, HoldingsChannel.com reports. The firm bought 1,500 shares of the healthcare conglomerate’s stock, valued at approximately $759,000.

A number of other institutional investors have also made changes to their positions in the business. R.H. Investment Group LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $3,483,000. Oak Thistle LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $563,000. Nabity Jensen Investment Management Inc lifted its position in UnitedHealth Group by 1.9% in the fourth quarter. Nabity Jensen Investment Management Inc now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,384,000 after purchasing an additional 50 shares during the period. Wiser Wealth Management Inc raised its stake in shares of UnitedHealth Group by 14.5% in the 4th quarter. Wiser Wealth Management Inc now owns 482 shares of the healthcare conglomerate’s stock valued at $244,000 after buying an additional 61 shares in the last quarter. Finally, ARS Wealth Advisors Group LLC raised its position in UnitedHealth Group by 0.6% in the fourth quarter. ARS Wealth Advisors Group LLC now owns 27,646 shares of the healthcare conglomerate’s stock worth $13,985,000 after purchasing an additional 165 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UNH opened at $273.96 on Friday. The company has a fifty day moving average price of $474.72 and a two-hundred day moving average price of $515.82. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $248.52 billion, a PE ratio of 17.67, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the company posted $6.91 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 3.07%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on UNH shares. Truist Financial lowered their price target on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a research report on Monday, April 21st. Raymond James cut shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research note on Wednesday. Mizuho boosted their target price on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Finally, Erste Group Bank downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. Six research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $508.38.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.